Cargando…

Genetic heterogeneity in patients with Bartter syndrome type 1

Bartter syndrome (BS) type 1 is an autosomal recessive kidney disorder caused by loss-of-function mutations in the solute carrier family 12 member 1 (SLC12A1) gene. To date, 72 BS type 1 patients harboring SLC12A1 mutations have been documented. Of these 144 alleles studied, 68 different disease-cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Mingran, Ning, Jing, Xu, Weihong, Zhang, Han, Zhao, Kaishu, Li, Wenfu, Li, Guiying, Li, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364841/
https://www.ncbi.nlm.nih.gov/pubmed/28000888
http://dx.doi.org/10.3892/mmr.2016.6063
_version_ 1782517403990622208
author Sun, Mingran
Ning, Jing
Xu, Weihong
Zhang, Han
Zhao, Kaishu
Li, Wenfu
Li, Guiying
Li, Shibo
author_facet Sun, Mingran
Ning, Jing
Xu, Weihong
Zhang, Han
Zhao, Kaishu
Li, Wenfu
Li, Guiying
Li, Shibo
author_sort Sun, Mingran
collection PubMed
description Bartter syndrome (BS) type 1 is an autosomal recessive kidney disorder caused by loss-of-function mutations in the solute carrier family 12 member 1 (SLC12A1) gene. To date, 72 BS type 1 patients harboring SLC12A1 mutations have been documented. Of these 144 alleles studied, 68 different disease-causing mutations have been detected in 129 alleles, and no mutation was detected in the remaining 15 alleles. The mutation types included missense/nonsense mutations, splicing mutations and small insertions and deletions ranging from 1 to 4 nucleotides. A large deletion encompassing a whole exon in the SLC12A1 gene has not yet been reported. The current study initially identified an undocumented homozygous frameshift mutation (c.1833delT) by Sanger sequencing analysis of a single infant with BS type 1. However, in a subsequent analysis, the mutation was detected only in the father's DNA. Upon further investigation using a next-generation sequencing approach, a deletion in exons 14 and 15 in both the patient and patient's mother was detected. The deletion was subsequently confirmed by use of a long-range polymerase chain reaction and was determined to be 3.16 kb in size based on sequencing of the junction fragment. The results of the present study demonstrated that pathogenic variants of SLC12A1 are heterogeneous. Large deletions appear to serve an etiological role in BS type 1, and may be more prevalent than previously thought.
format Online
Article
Text
id pubmed-5364841
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-53648412017-05-15 Genetic heterogeneity in patients with Bartter syndrome type 1 Sun, Mingran Ning, Jing Xu, Weihong Zhang, Han Zhao, Kaishu Li, Wenfu Li, Guiying Li, Shibo Mol Med Rep Articles Bartter syndrome (BS) type 1 is an autosomal recessive kidney disorder caused by loss-of-function mutations in the solute carrier family 12 member 1 (SLC12A1) gene. To date, 72 BS type 1 patients harboring SLC12A1 mutations have been documented. Of these 144 alleles studied, 68 different disease-causing mutations have been detected in 129 alleles, and no mutation was detected in the remaining 15 alleles. The mutation types included missense/nonsense mutations, splicing mutations and small insertions and deletions ranging from 1 to 4 nucleotides. A large deletion encompassing a whole exon in the SLC12A1 gene has not yet been reported. The current study initially identified an undocumented homozygous frameshift mutation (c.1833delT) by Sanger sequencing analysis of a single infant with BS type 1. However, in a subsequent analysis, the mutation was detected only in the father's DNA. Upon further investigation using a next-generation sequencing approach, a deletion in exons 14 and 15 in both the patient and patient's mother was detected. The deletion was subsequently confirmed by use of a long-range polymerase chain reaction and was determined to be 3.16 kb in size based on sequencing of the junction fragment. The results of the present study demonstrated that pathogenic variants of SLC12A1 are heterogeneous. Large deletions appear to serve an etiological role in BS type 1, and may be more prevalent than previously thought. D.A. Spandidos 2017-02 2016-12-21 /pmc/articles/PMC5364841/ /pubmed/28000888 http://dx.doi.org/10.3892/mmr.2016.6063 Text en Copyright: © Sun et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Sun, Mingran
Ning, Jing
Xu, Weihong
Zhang, Han
Zhao, Kaishu
Li, Wenfu
Li, Guiying
Li, Shibo
Genetic heterogeneity in patients with Bartter syndrome type 1
title Genetic heterogeneity in patients with Bartter syndrome type 1
title_full Genetic heterogeneity in patients with Bartter syndrome type 1
title_fullStr Genetic heterogeneity in patients with Bartter syndrome type 1
title_full_unstemmed Genetic heterogeneity in patients with Bartter syndrome type 1
title_short Genetic heterogeneity in patients with Bartter syndrome type 1
title_sort genetic heterogeneity in patients with bartter syndrome type 1
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364841/
https://www.ncbi.nlm.nih.gov/pubmed/28000888
http://dx.doi.org/10.3892/mmr.2016.6063
work_keys_str_mv AT sunmingran geneticheterogeneityinpatientswithbarttersyndrometype1
AT ningjing geneticheterogeneityinpatientswithbarttersyndrometype1
AT xuweihong geneticheterogeneityinpatientswithbarttersyndrometype1
AT zhanghan geneticheterogeneityinpatientswithbarttersyndrometype1
AT zhaokaishu geneticheterogeneityinpatientswithbarttersyndrometype1
AT liwenfu geneticheterogeneityinpatientswithbarttersyndrometype1
AT liguiying geneticheterogeneityinpatientswithbarttersyndrometype1
AT lishibo geneticheterogeneityinpatientswithbarttersyndrometype1